Imatinib in Systemic Sclerosis

Clinical trial NCT00506831 · COMPLETED

Trial details

NCT number: NCT00506831
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Scleroderma, Systemic

Start date: 2007-07-01
Primary completion: 2010-09-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.